Device Trial Radar · NCT02000115
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Last checked: Nov 20, 2026Latest source record: Jul 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,242
Actual
Start
May 2014
Primary completion
Oct 2019
Study completion Dec 2026
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Dec 3, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the PORTICO pivotal IDE trial is to evaluate the safety and effectiveness of the St Jude Medical (SJM) Portico Transcatheter Heart Valve and Delivery Systems (Portico) in the treatment of severe symptomatic aortic stenosis via transfemoral and alternative delivery methods in high risk and extreme risk patients.
Conditions
- Aortic Valve Stenosis
Interventions
Portico transcatheter aortic valveDevice
St. Jude Medical transcatheter Portico aortic valve
Commercially available transcatheter aortic valveDevice
Commercially available transcatheter aortic valve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness Endpoint (Randomized IDE Cohort)Time frame: One-year from randomization
- Primary Safety Endpoint (Randomized IDE Cohort)Time frame: 30 days from randomization
- Percentage of Patients With Major Vascular Complications (Primary Safety Endpoint- FlexNav Delivery System Study)Time frame: 30 days from index procedure
Locations
70 sites in 2 countries. Site status is shown where the registry gives one.
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama
Banner - University Medical Center Phoenix
Phoenix, Arizona
John Muir Medical Center
Concord, California
67 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.